Specifically, in invasive breast cancer cell lines, the reduction of Orai3 through knockdown led to a decline in cell migration, while the augmentation of Orai3 expression resulted in an enhancement of cellular motility [53]. This evidence concerns the gene ORAI3 and breast carcinoma.